Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal IgG1 antibody against programmed death ligand-1

EU orphan designation number: EU/3/15/1590   
Active ingredient: Recombinant human monoclonal IgG1 antibody against programmed death ligand-1
Indication: Treatment of Merkel cell carcinoma
Sponsor: Merck Serono Europe Limited
56, Marsh Wall, London E14 9TP, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2015 Orphan designation EMA/OD/150/15 (2015)9511 of 14/12/2015
22/08/2016 Transfer of orphan designation EMA/OD/150/15/T/01 (2016)5451 of 18/08/2016